Current Drug Targets
Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Drug Targets, Volume 21 - Number 14
Biography Open Access
Editorial Open Access
Review Article (Mini-Review)
Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer
, 21(14): 1397 - 1404Adrian Bartoszek, Jakub Fichna, Aleksandra Tarasiuk, Agata Binienda, Adam Fabisiak, Julia B. Krajewska, Paula Mosińska, Karolina Niewinna and Maciej Salaga*
DOI: 10.2174/1389450120666191112141901
Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer
Review Article (Mini-Review)
The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy
, 21(14): 1405 - 1416Agata Binienda, Sylwia Ziolkowska, Ingvild H. Hauge and Maciej Salaga*
DOI: 10.2174/1389450121666200504074922
The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy
Review Article
Nutritional Support and Probiotics as a Potential Treatment of IBD
, 21(14): 1417 - 1427Aleksandra Tarasiuk and Guido Eibl*
DOI: 10.2174/1389450121666200504075519
Nutritional Support and Probiotics as a Potential Treatment of IBD
Review Article
Targeting Enteric Neurons and Plexitis for the Management of Inflammatory Bowel Disease
, 21(14): 1428 - 1439Rhian Stavely, Raquel Abalo and Kulmira Nurgali*
DOI: 10.2174/1389450121666200516173242
Targeting Enteric Neurons and Plexitis for the Management of Inflammatory Bowel Disease
Review Article
Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future Challenges
, 21(14): 1440 - 1447Hubert Zatorski and Radislav Nakov*
DOI: 10.2174/1389450121666200602125507
Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future Challenges
Review Article
Exosomes in Inflammatory Bowel Disease: What Have We Learned So Far?
, 21(14): 1448 - 1455Haichao Wang, Chen Ye, Yaling Wu, Pengyu Yang, Chunqiu Chen, Zhanju Liu and Xiaolei Wang*
DOI: 10.2174/1389450121666200428102330
Exosomes in Inflammatory Bowel Disease: What Have We Learned So Far?
Review Article
Single Nucleotide Polymorphisms in Colitis-Associated Colorectal Cancer: A Current Overview with Emphasis on the Role of the Associated Genes Products
, 21(14): 1456 - 1462Adam Makaro, Jakub Fichna and Marcin Włodarczyk*
DOI: 10.2174/1389450121666200727105218
Single Nucleotide Polymorphisms in Colitis-Associated Colorectal Cancer: A Current Overview with Emphasis on the Role of the Associated Genes Products
General Review Article
Immunotherapy and Radiation Therapy in Renal Cell Carcinoma
, 21(14): 1463 - 1475Veronica Mollica, Matteo Santoni, Vincenzo Di Nunno, Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Nicola Battelli, Rodolfo Montironi and Francesco Massari*
DOI: 10.2174/1389450121666200311121540
Immunotherapy and Radiation Therapy in Renal Cell Carcinoma
General Review Article
Antimicrobial Terpenoids as a Potential Substitute in Overcoming Antimicrobial Resistance
, 21(14): 1476 - 1494Aditi Sharma, Avadh Biharee, Amit Kumar and Vikas Jaitak*
DOI: 10.2174/1389450121666200520103427
Antimicrobial Terpenoids as a Potential Substitute in Overcoming Antimicrobial Resistance
General Review Article
Characteristic of Cyclodextrins: Their Role and Use in the Pharmaceutical Technology
, 21(14): 1495 - 1510Malwina Lachowicz*, Andrzej Stańczak and Michał Kołodziejczyk
DOI: 10.2174/1389450121666200615150039
Characteristic of Cyclodextrins: Their Role and Use in the Pharmaceutical Technology
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Webmaster Contact: info@benthamscience.net